Cargando…

MiR-125 Family in Cardiovascular and Cerebrovascular Diseases

Cardiovascular and cerebrovascular diseases are a serious threaten to the health of modern people. Understanding the mechanism of occurrence and development of cardiovascular and cerebrovascular diseases, as well as reasonable prevention and treatment of them, is a huge challenge that we are current...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Tan, Jing, Wang, Lu, Pei, Gaiqin, Cheng, Hongxin, Zhang, Qing, Wang, Shiqi, He, Chengqi, Fu, Chenying, Wei, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674784/
https://www.ncbi.nlm.nih.gov/pubmed/34926475
http://dx.doi.org/10.3389/fcell.2021.799049
_version_ 1784615749859409920
author Wang, Yang
Tan, Jing
Wang, Lu
Pei, Gaiqin
Cheng, Hongxin
Zhang, Qing
Wang, Shiqi
He, Chengqi
Fu, Chenying
Wei, Quan
author_facet Wang, Yang
Tan, Jing
Wang, Lu
Pei, Gaiqin
Cheng, Hongxin
Zhang, Qing
Wang, Shiqi
He, Chengqi
Fu, Chenying
Wei, Quan
author_sort Wang, Yang
collection PubMed
description Cardiovascular and cerebrovascular diseases are a serious threaten to the health of modern people. Understanding the mechanism of occurrence and development of cardiovascular and cerebrovascular diseases, as well as reasonable prevention and treatment of them, is a huge challenge that we are currently facing. The miR-125 family consists of hsa-miR-125a, hsa-miR-125b-1 and hsa-miR-125b-2. It is a kind of miRNA family that is highly conserved among different species. A large amount of literature shows that the lack of miR-125 can cause abnormal development of the cardiovascular system in the embryonic period. At the same time, the miR-125 family participates in the occurrence and development of a variety of cardiovascular and cerebrovascular diseases, including myocardial ischemia, atherosclerosis, ischemia-reperfusion injury, ischemic stroke, and heart failure directly or indirectly. In this article, we summarized the role of the miR-125 family in the development and maturation of cardiovascular system, the occurrence and development of cardiovascular and cerebrovascular diseases, and its important value in the current fiery stem cell therapy. In addition, we presented this in the form of table and diagrams. We also discussed the difficulties and challenges faced by the miR-125 family in clinical applications.
format Online
Article
Text
id pubmed-8674784
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86747842021-12-17 MiR-125 Family in Cardiovascular and Cerebrovascular Diseases Wang, Yang Tan, Jing Wang, Lu Pei, Gaiqin Cheng, Hongxin Zhang, Qing Wang, Shiqi He, Chengqi Fu, Chenying Wei, Quan Front Cell Dev Biol Cell and Developmental Biology Cardiovascular and cerebrovascular diseases are a serious threaten to the health of modern people. Understanding the mechanism of occurrence and development of cardiovascular and cerebrovascular diseases, as well as reasonable prevention and treatment of them, is a huge challenge that we are currently facing. The miR-125 family consists of hsa-miR-125a, hsa-miR-125b-1 and hsa-miR-125b-2. It is a kind of miRNA family that is highly conserved among different species. A large amount of literature shows that the lack of miR-125 can cause abnormal development of the cardiovascular system in the embryonic period. At the same time, the miR-125 family participates in the occurrence and development of a variety of cardiovascular and cerebrovascular diseases, including myocardial ischemia, atherosclerosis, ischemia-reperfusion injury, ischemic stroke, and heart failure directly or indirectly. In this article, we summarized the role of the miR-125 family in the development and maturation of cardiovascular system, the occurrence and development of cardiovascular and cerebrovascular diseases, and its important value in the current fiery stem cell therapy. In addition, we presented this in the form of table and diagrams. We also discussed the difficulties and challenges faced by the miR-125 family in clinical applications. Frontiers Media S.A. 2021-12-02 /pmc/articles/PMC8674784/ /pubmed/34926475 http://dx.doi.org/10.3389/fcell.2021.799049 Text en Copyright © 2021 Wang, Tan, Wang, Pei, Cheng, Zhang, Wang, He, Fu and Wei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Wang, Yang
Tan, Jing
Wang, Lu
Pei, Gaiqin
Cheng, Hongxin
Zhang, Qing
Wang, Shiqi
He, Chengqi
Fu, Chenying
Wei, Quan
MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
title MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
title_full MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
title_fullStr MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
title_full_unstemmed MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
title_short MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
title_sort mir-125 family in cardiovascular and cerebrovascular diseases
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674784/
https://www.ncbi.nlm.nih.gov/pubmed/34926475
http://dx.doi.org/10.3389/fcell.2021.799049
work_keys_str_mv AT wangyang mir125familyincardiovascularandcerebrovasculardiseases
AT tanjing mir125familyincardiovascularandcerebrovasculardiseases
AT wanglu mir125familyincardiovascularandcerebrovasculardiseases
AT peigaiqin mir125familyincardiovascularandcerebrovasculardiseases
AT chenghongxin mir125familyincardiovascularandcerebrovasculardiseases
AT zhangqing mir125familyincardiovascularandcerebrovasculardiseases
AT wangshiqi mir125familyincardiovascularandcerebrovasculardiseases
AT hechengqi mir125familyincardiovascularandcerebrovasculardiseases
AT fuchenying mir125familyincardiovascularandcerebrovasculardiseases
AT weiquan mir125familyincardiovascularandcerebrovasculardiseases